Skip to main content

Novo Nordisk lifts dividend, launches $4.09 billion share buyback after earnings beat forecasts

Novo Nordisk global sales were driven by diabetes and obesity care sales.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.